When to Take NMN: A Usage Guide For MENA
Last updated: 4 November 2026
Quick answer: there is no proven "best" time to take NMN. Only one human study has compared timings: in older Japanese adults, 250 mg taken in the afternoon was linked to slightly better results on a chair-stand test and less daytime drowsiness than morning intake. Human trials have used between 250 mg and 2,000 mg a day, for two to 24 weeks. Take NMN at the same time each day, follow the label and speak to your doctor first if you have a medical condition or take medication.
What is NMN?
NMN (nicotinamide mononucleotide) is a compound the body uses to make NAD+, a molecule found in every cell and involved in energy metabolism. NAD+ levels tend to fall with age, which is why NMN is being studied in healthy-ageing research. Human research is still at an early stage: most trials are small and short, and many were run in Japan.
What human studies have found
Studies have looked at NMN mainly in healthy adults and older people. In summary:
- Blood NAD+ levels: several randomised, placebo-controlled trials found that taking NMN raised NAD+ or related compounds in the blood. Examples include 250 mg a day for 12 weeks in 30 healthy adults (Okabe et al., 2022) and 300, 600 or 900 mg a day for 60 days in 80 healthy middle-aged adults, where levels were highest in the 600 mg and 900 mg groups (Yi et al., 2023).
- Physical performance: in the same 60-day trial, walking distance in a six-minute walk test rose more in the NMN groups than with placebo (Yi et al., 2023). In healthy older men taking 250 mg a day for 6 or 12 weeks, researchers saw small improvements in walking speed and left-hand grip strength, which they said should be confirmed in larger studies (Igarashi et al., 2022). A trial in 48 amateur runners who were also training found improvements in some aerobic measures at 600 mg and 1,200 mg a day over six weeks, but no change in maximum oxygen uptake (VO2max) (Liao et al., 2021).
- Sleep: in 60 older adults taking 250 mg a day for 12 weeks, sleep-quality questionnaire scores were better than with placebo (Morifuji et al., 2024).
- Metabolism: in 25 postmenopausal women with prediabetes and overweight or obesity, 250 mg a day for 10 weeks increased muscle insulin sensitivity compared with placebo (Yoshino et al., 2021).
These are early findings from small groups of people. They do not show that NMN slows ageing, and NMN is not intended to treat, cure or prevent any disease.
Morning or afternoon? What the timing study found
A 12-week randomised, double-blind study gave 108 older Japanese adults 250 mg of NMN or a placebo, either in the morning or in the afternoon. The group taking NMN in the afternoon had the largest improvement in a five-times sit-to-stand test and in drowsiness scores (Kim et al., 2022).
This is a single study in older adults, so it does not prove that afternoon is best for everyone. In practice, many people take NMN in the morning or early afternoon simply because it fits their routine. Consistency matters more than the exact hour.
With or without food?
We are not aware of any human study that has compared taking NMN with food against taking it on an empty stomach. Claims that one is "better for absorption" are not backed by human data. If capsules or powder upset your stomach, try taking them with a meal.
How much NMN have studies used?
| Study | Who took part | Daily amount | Duration |
|---|---|---|---|
| Irie et al., 2020 | 10 healthy men | Single doses of 100, 250 and 500 mg | Single dose |
| Okabe et al., 2022 | 30 healthy adults | 250 mg | 12 weeks |
| Kim et al., 2022 | 108 older adults | 250 mg | 12 weeks |
| Yi et al., 2023 | 80 healthy middle-aged adults | 300, 600 or 900 mg | 60 days |
| Liao et al., 2021 | 48 amateur runners | 300, 600 or 1,200 mg | 6 weeks |
| Fukamizu et al., 2022 | 31 healthy adults aged 20–65 | 1,250 mg | 4 weeks |
A 2026 systematic review of randomised trials, covering doses of 250–2,000 mg a day for 14 days to 24 weeks, found that NMN did not increase adverse events or liver enzymes compared with control groups (Yang et al., 2026). Long-term safety beyond six months has not been studied.
Each Charava NMN capsule contains 500 mg. Follow the dose on the label.
Capsules or powder?
The NMN is the same. Capsules give a fixed 500 mg dose with no measuring. Powder lets you adjust the amount and mix it into water. See our NMN powder vs capsules guide.
Who should not take NMN?
NMN is not recommended for anyone under 18, or during pregnancy or breastfeeding. If you have a medical condition or take medication, speak to your doctor or pharmacist first.
Buying NMN in the UAE
Charava's NMN supplements, including NMN 500mg capsules and NMN powder, ship from our UAE warehouse to Dubai, Abu Dhabi, the rest of the UAE and the wider GCC.
Frequently asked questions
What is the best time of day to take NMN?
There is no proven best time. One study in older adults found slightly better results with afternoon intake than morning intake. Choose a time you can stick to.
How long does NMN take to work?
Human trials have measured changes in blood NAD+ after 4–12 weeks. Whether you notice any difference in how you feel varies, and no result is guaranteed.
Can I take NMN with resveratrol?
Some people do, but we are not aware of published human trials testing the combination. If you take other supplements or medicines, check with a pharmacist.
References
- Kim M, et al. Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study. Nutrients. 2022;14(4):755. PubMed 35215405
- Yi L, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023;45(1):29–43. PubMed 36482258
- Igarashi M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. NPJ Aging. 2022;8(1):5. PubMed 35927255
- Liao B, et al. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr. 2021;18(1):54. PubMed 34238308
- Morifuji M, et al. Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study. GeroScience. 2024;46(5):4671–4688. PubMed 38789831
- Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224–1229. PubMed 33888596
- Okabe K, et al. Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects. Front Nutr. 2022;9:868640. PubMed 35479740
- Irie J, et al. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocr J. 2020;67(2):153–160. PubMed 31685720
- Fukamizu Y, et al. Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women. Sci Rep. 2022;12(1):14442. PubMed 36002548
- Yang W, et al. Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis. Nutrients. 2026;18(14):2251. PubMed 42514320
This article is for general information only and is not medical advice. Food supplements are not intended to diagnose, treat, cure or prevent any disease and should not replace a varied, balanced diet and a healthy lifestyle. Always follow the label and speak to a qualified healthcare professional before starting a new supplement.
